| Placental growth factor: a predictive marker for preeclampsia? | |
| | |
MedLine Citation:
|
PMID: 19346754 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: An imbalance between angiogenic and antiangiogenic factors plays a fundamental role in the pathogenesis of preeclampsia. Serum levels of placental growth factor (PLGF), a factor promoting angiogenesis, in patients with preeclampsia are significantly lower than in nonpreeclamptic pregnancies. This study was designed to answer the question whether the measurement of PLGF at the beginning of the second trimester might be a predictive factor for the appearance of preeclampsia. METHODS: Serum samples of 61 women were collected between 15 and 18 weeks of pregnancy. PLGF levels were measured using a human PLGF ELISA and correlated with the outcomes of pregnancy. RESULTS: 7 women (11.47%) developed preeclampsia during pregnancy. Their PLGF levels between 15 and 18 weeks of pregnancy were significantly lower (p < 0.001) compared to the nonpreeclamptic pregnancies. Using a PLGF level of 41.84 pg/ml as a cutoff, this test has a sensitivity of 0.87 and a specificity of 0.83. CONCLUSION: Women who will develop preeclampsia in the course of pregnancy already have a significantly lower expression of PLGF between 15 and 18 weeks of pregnancy compared to those who will not. This test offers new possibilities in the prediction of preeclampsia. |
| | |
Authors:
|
Markus Schmidt; Canan Dogan; Cahit Birdir; Ulrich Kuhn; Alexandra Gellhaus; Rainer Kimmig; Sabine Kasimir-Bauer |
Related Documents
:
|
4177614 - Serum fibrin degradation products throughout normal pregnancy. 6868964 - Gastrin and gastrointestinal dyspepsia in pregnancy. 22420034 - Persistent pulmonary hypertension of the newborn and selective serotonin reuptake inhib... 14988604 - Lipid-soluble antioxidants and pregnancy: maternal serum levels of coenzyme q10, alpha-... 8676044 - Pulsatile and diurnal secretion of gh and igf-i in the chronically catheterized pig fetus. 12470524 - Impact of urinary fsh price: a cost-effectiveness analysis of recombinant and urinary f... |
Publication Detail:
|
Type: Journal Article Date: 2009-03-25 |
Journal Detail:
|
Title: Gynäkologisch-geburtshilfliche Rundschau Volume: 49 ISSN: 1423-0011 ISO Abbreviation: Gynakol Geburtshilfliche Rundsch Publication Date: 2009 |
Date Detail:
|
Created Date: 2009-04-06 Completed Date: 2009-07-07 Revised Date: 2009-11-25 |
Medline Journal Info:
|
Nlm Unique ID: 9212667 Medline TA: Gynakol Geburtshilfliche Rundsch Country: Switzerland |
Other Details:
|
Languages: eng Pagination: 94-9 Citation Subset: IM |
Copyright Information:
|
Copyright 2009 S. Karger AG, Basel. |
Affiliation:
|
Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany. markus.schmidt@uk-essen.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Biological Markers / blood Female Humans Pre-Eclampsia / blood*, diagnosis* Pregnancy Pregnancy Proteins / blood* Pregnancy Trimester, First Reproducibility of Results Sensitivity and Specificity |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 0/Pregnancy Proteins; 144589-93-5/placenta growth factor |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Weight gain due to hormonal contraception: myth or truth?
Next Document: Skin biopsies demonstrate site-specific endothelial activation in mouse models of sepsis.